ContraFect Corp (CFRX)

NASDAQ
0.061
-0.007(-10.37%)
After Hours
0.063
+0.001(+2.443%)
- Real-time Data
  • Volume:
    22,757,966
  • Day's Range:
    0.059 - 0.070
  • 52 wk Range:
    0.059 - 4.540
Unusual trading volume

ContraFect Corp has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

1 / 2

CFRX Overview

Prev. Close
0.069
Day's Range
0.059-0.07
Revenue
-
Open
0.065
52 wk Range
0.059-4.54
EPS
-1.52
Volume
22,757,966
Market Cap
2.66M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
7,488,797
P/E Ratio
-0.04
Beta
0.341
1-Year Change
-97.28%
Shares Outstanding
43,682,721
Next Earnings Date
16 Mar 2023
What is your sentiment on ContraFect Corp?
or
Market is currently closed. Voting is open during market hours.

ContraFect Corp News

ContraFect Corp Analysis

ContraFect Corp Company Profile

ContraFect Corp Company Profile

ContraFect Corporation is a late clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase (CF-301), is used for the treatment of methicillin-resistant S. aureus (MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa and has demonstrated potent in vivo activity against extensively drug-resistant (XDR) strains. It has developed an, engineered variant of exebacase, known as CF-296. It is conducting further in vitro and in vivo characterization of CF-296 to evaluate the full profile of this compound.

Read More

Analyst Price Target

Average5.000 (+8,096.721% Upside)
High7.000
Low3.000
Price0.061
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Going above $10 June 2022
    0